Blood Coagulation/ Clotting prevents excessive bleeding during an injury or surgery. Coagulation tests measure blood’s ability and the duration it takes to clot. These tests help clinicians to assess the risk of excessive bleeding or developing clots (thrombosis) in the blood vessels. Clinicians frequently order coagulation tests to assess blood clotting function in patients before performing surgeries or in treatments of disorders related to arteries.
Coagulation tests help in determining the probable bleeding rate in the perioperative or postoperative period. These laboratory tests are also helpful in elucidating the cause of unexplained bleeding and predicting blood clotting or thrombosis in the absence of vessel injury. The global blood coagulation testing market appears to be well-established with the availability of many well-described assays. The market is growing pervasively over the past few years. The market is predominantly driven by the rising prevalence of the liver disease, von Willebrand disease (vWF), and hemophilia and increasing per capita healthcare expenses. Significant technological strides in testing devices led by the substantial investments transpired by the private & public organization are escalating the market on a global level, driving R&D activities.
According to Market Research Future
(MRFR), the global Blood Coagulation
Testing Market size was valued at
USD 2.5 billion in 2022 and is projected to grow from USD 2.64 Billion in 2023
to USD 3.94 billion by 2032, exhibiting a compound annual growth rate (CAGR) of
5.7% during the forecast period (2023 - 2032).
Growing liver failure cases foster market
growth, driving the demand for blood coagulation tests. Well-spread awareness about various
diseases and disorders related to liver, hemophilia, and vWF driven through
various governmental initiatives acts as a major tailwind pushing the growth of
the blood coagulation testing market, further. Additional factors, such as the
increasing population, sedentary lifestyle, and urbanization support market
growth.
Market Segmentation
·
The
global market for blood coagulation is segmented on the basis of product,
application, test type, and end user.
·
The
products available in the blood coagulation market are automated testing, clinical laboratory, and semi-automated testing.
·
On the
basis of application, the blood coagulation market has been segmented into
acquired bleeding disorders, hemophilia, congenital bleeding disorders, and Von
Willebrand disease.
·
By
test type, the global blood coagulation market has been segmented into various
testing kits and others. Additionally, testing kits are sub-segmented into
activated clotting time, D dimer, and fibrinogen, (FIB prothrombin time (PT).
·
by end
user, the global blood coagulation market is segmented into academic
institutions, diagnostic laboratories, and hospitals.
Regional Analysis
The
Americas dominates the global blood coagulation testing market owing to the
increasing patient with liver disease, hemophilia, and von Willebrand disease
(vWF). Additionally, in North America, the early adoption of advanced
technology, increasing government initiatives for research and development
activities, high health care expenditure, and the presence of several
significant companies contribute to the growth of the blood coagulation market
in this region during the evaluation period.
European
region accounts for the second largest region in the global blood coagulation
testing market and is likely to maintain its market share over the evaluation
period. The notable growth of the region is owing to the increasing initiatives
and expenditure of the government towards research and development activities.
This is projected to continue to drive the European market over the forecast
period. Additionally, developing countries such as Germany and France are
increasing their investment in the healthcare domain to improve medical
facilities.
The
Asia Pacific (APAC) region is the fastest growing blood coagulation testing
market over the assessment period. This is attributed to the presence of
rapidly developing healthcare technology, expansion of medical infrastructure,
a vast patient populace, and higher healthcare expenditure. Furthermore,
increasing demand for the introduction of new treatment methods in countries
like India, Japan, and South Korea is likely to contribute to the substantial
market share over the review period. Additionally, growing demand for quality
devices in the healthcare is anticipated to increase the adoption of advanced
equipment, which, consequently, is likely to surge the growth of the market in
the region during the forecast period.
the
Middle East and Africa (MEA) region is accounted for the smallest market share
over the review period. This is accredited to the increasing prevalence of
blood disorders, which have become a massive problem owing to ignorance of
diseases, lack of consumer awareness, limited screening, and poor access to
treatment. The increase in government initiatives to improve the healthcare
sector to offer necessary medical facilities, expand the infrastructure, and
adopt advanced healthcare technologies, is expected to contribute substantially
to the market share over the evaluation period. Additionally, the middle
eastern developing countries are expected to contribute to the majority of the
market share.
Key Players
The
key players acknowledged in the global Blood Coagulation Testing Market players are Accriva Diagnostics (U.S.A.), Alere
Inc. (U.S.), Bio/Data Corporation (U.S.), CoaguSense, Inc. (U.S.),F.
Hoffmann-La Roche Ltd. (Europe), HomoSonics LLC. (U.S.), iLine Microsystems.
(Europe), Instrumentation Laboratory (U.S.), Siemens Healthcare Private Limited
(Europe), Sienco, Inc. (U.S.), SenGenix Inc. (U.S.).
At Market Research Future (MRFR), we
enable our customers to unravel the complexity of various industries through
our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
0 Comments